Walleye Capital
MRSN

Walleye Capital’s Mersana Therapeutics MRSN Stock Holding History

Walleye Capital’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-80,859
Closed -$2.57M – 5562
2023
Q3 		$2.57M Buy
80,859
+74,663
+1,205% +$3.55M 0.04% 1537
2023
Q2 		$510K Sell
6,196
-2,740
-31% -$401K 0.01% 2427
2023
Q1 		$918K Buy
+8,936
New +$1.25M 0.02% 1217
2022
Q3 		– Sell
-411
Closed -$47K – 3528
2022
Q2 		$47K Sell
411
-15,359
-97% -$1.44M ﹤0.01% 1829
2022
Q1 		$1.57M Sell
15,770
-20
-0.1% -$2.34K 0.05% 442
2021
Q4 		$2.46M Buy
15,790
+11,018
+231% +$2.14M 0.08% 285
2021
Q3 		$1.13K Buy
4,772
+3,219
+207% +$940K 0.03% 398
2021
Q2 		$527 Buy
+1,553
New +$588K 0.02% 730
2019
Q4 		– Sell
-570
Closed -$23K – 2299
2019
Q3 		$23K Buy
570
+10
+2% +$727 0.02% 1716
2019
Q2 		$57K Buy
+560
New +$66K 0.06% 1355

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return